NAVINFLUORNSENavin Fluorine International Limited· Chemicals - InorganicHighPositive
Announced Fri, 9 May · 16:46 IST

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015( SEBI Listing Regulations ), we wish to inform you that the Board of Directors of the Company have,inter alia, taken the following decisions at their Meeting held today:1. Annual Audited Standalone and Consolidated Financial ResultsPursuant to Regulation 33 of SEBI Listing Regulations, the Board Directors of the Company, hasapproved the Annual Audited Standalone and Consolidated Financial Results of the Companyfor the financial year ended March 31, 2025. Please find enclosed the following in this regard: Audited Consolidated Financial Results in the prescribed form along with Auditors Reportthereon from Price Waterhouse Chartered Accountants LLP, Statutory Auditors -Annexure A Audited Standalone Financial Results in the prescribed form along with Auditors Reportthereon from Price Waterhouse Chartered Accountants LLP, Statutory Auditors -Annexure B Declaration by Chief Financial Officer regarding Unmodified Opinion on the AnnualAudited Standalone and Consolidated Financial Results - Annexure C2. Final DividendThe Board of Directors has recommended final dividend of ₹7/- per equity share of the face valueof ₹2/- each (i.e. 350% of the face value) for the financial year 2024-2025 subject to approval ofthe Members of the Company at the forthcoming 27th Annual General Meeting to be held onJuly 31, 2025.3. Record Date for Final DividendAs per Regulation 42 of SEBI Listing Regulations, Friday, July 04, 2025 is fixed as Record Datefor ascertaining eligibility for the payment of final dividend for the financial year 2024-2025, ifdeclared. On declaration, the final dividend will be paid on or after Friday, August 08, 2025.4. Re-appointment of Mr. Ashok U. Sinha as an Independent Director of the Company:Based on the recommendation of the Nomination and Remuneration Committee, the Boardhas approved the re-appointment of Mr. Ashok U. Sinha (DIN: 00070477) as an IndependentDirector of the Company, not liable to retire by rotation, to hold office for a term of5 consecutive years commencing from October 28, 2025, subject to approval of the Membersof the Company, notwithstanding that he shall attain the age of 75 years during such term.Mr. Sinha is not related to any Director of the Company. Further, in accordance with theCircular issued by BSE Limited and National Stock Exchange of India Limited dated June 20,2018, it is confirmed that Mr. Sinha is not debarred from holding the office of director by virtueof any order of the SEBI or any other such authority. Brief Profile of Mr. Sinha is enclosed -Annexure D.5. Appointment of Parikh & Associates, Practising Company Secretaries as Secretarial Auditorsof the Company:Based on the recommendation of the Audit Committee, the Board of Directors has approved,the appointment of Parikh & Associates, Practising Company Secretaries as SecretarialAuditors of the Company for Secretarial Audit for 5 consecutive years commencing fromFinancial Year 2025-2026 till Financial Year 2029-2030, subject to approval of the Members ofthe Company at the forthcoming 27th Annual General Meeting. The relevant details areprovided in - Annexure E.6. Raising funds by way of issuance of equity shares or any other instruments or securitiesthrough qualified institutional placement / private placement / public issue / preferentialissue or through any other permissible mode or combination thereof:Pursuant to Regulation 30 of SEBI Listing Regulations, as amended, and other applicable laws,the Board of Directors of the Company has approved the proposal of fund raising by way ofissuance of such number of equity shares having face value of ₹ 2 each of the Company ( EquityShares ), Global Depository Receipts ( GDRs ), American Depository Receipts ( ADRs ),Foreign Currency Convertible Bonds ( FCCBs ) and/or other securities convertible into EquityShares (including warrants, or otherwise), fully convertible debentures, partly convertibledebentures, non-convertible debentures with warrants and/or convertible preference sharesor any security convertible into Equity Shares (hereinafter referred to as Securities ), or anycombination thereof, in one or more tranches, whether Rupee denominated or denominatedin foreign currency, in the course of domestic and/or international offering(s) in one or more foreign markets, in terms of the applicable regulations and as permitted under the applicablelaws, in such manner in consultation with the book running lead manager(s) and/or otheradvisor(s) or otherwise, for an aggregate amount not exceeding ₹ 750 crores (INR SevenHundred and Fifty Crores only) or an equivalent amount thereof (inclusive of such premium asmay be fixed on such Securities) at such price or prices as may be permissible under applicablelaw by way of public issue, preferential allotment, private placement, including one or morequalified institutional placement of Equity Shares, or through any other permissible modeand/or combination thereof as may be considered appropriate in accordance with theprovisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, asamended, and all other applicable laws, and subject to the receipt of the necessary approvalsincluding governmental / regulatory / statutory approvals as may be required and the approvalof the Members of the Company at the forthcoming 27th Annual General Meeting scheduledto be held on July 31, 2025. The Board also approved ancillary actions for the abovementionedfund raising.The above-Board approval is in substance an extension (subject to Members approval) of theearlier resolution for another year.The Meeting commenced at 01:45 P.M. (IST) and concluded at 03:45 P.M. (IST).

Ebitda Margin ExpansionExceptional ItemResults View source PDF

NAVINFLUOR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Navin Fluorine's board approved FY25 audited results with consolidated revenue from operations rising to ₹2,349.38 cr (vs ₹2,065.01 cr in FY24, up ~13.8%) and profit after tax of ₹288.58 cr (vs ₹270.50 cr, up ~6.7%). Standalone revenue grew to ₹1,686.81 cr with PAT of ₹241.93 cr. The board recommended a final dividend of ₹7 per share (350% on face value of ₹2), taking total dividend for FY25 to ₹12 per share (interim of ₹5 already paid). The record date is July 4, 2025, with payment on or after August 8, 2025. Mr. Ashok U. Sinha was re-appointed as Independent Director for 5 years, Parikh & Associates were appointed as Secretarial Auditors for FY26–FY30, and a ₹750 crore fund-raising proposal (QIP/private placement/preferential issue) was approved as an extension of an earlier resolution, subject to shareholder approval at the July 31, 2025 AGM. Auditor Price Waterhouse issued an unmodified opinion on both standalone and consolidated results.

Likely market impact

Strong results with healthy revenue growth, improved margins, and a robust total dividend payout of ₹12/share are positive for shareholders. The ₹750 cr fund-raising approval is an enabling resolution (extension of an earlier one) and may cause some dilution concern, but execution depends on pricing and mode chosen at a later date.